Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
7.64
+0.05 (0.66%)
Aug 15, 2025, 10:45 AM - Market open

Passage Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Net Income
-56.86-64.77-102.06-136.13-185.39-112.23
Upgrade
Depreciation & Amortization
1.853.083.723.681.540.8
Upgrade
Loss (Gain) From Sale of Assets
--0.46---
Upgrade
Asset Writedown & Restructuring Costs
7.435.235.39381
Upgrade
Loss (Gain) From Sale of Investments
-0.66-1.53-2.040.772.780.63
Upgrade
Stock-Based Compensation
4.435.8210.9218.9532.6914.58
Upgrade
Other Operating Activities
8.248.23--2.080.26
Upgrade
Change in Accounts Payable
1.77-0.56-2.79-5.412.24.59
Upgrade
Change in Other Net Operating Assets
-2.28-3.478.13-3.089.229.85
Upgrade
Operating Cash Flow
-36.07-47.96-78.26-118.21-126.88-80.52
Upgrade
Capital Expenditures
-0.03-0.03-0.15-2.27-17.64-1.15
Upgrade
Sale (Purchase) of Intangibles
----3-8-0.5
Upgrade
Investment in Securities
67.7354.9865.3830.47-20.17-170.46
Upgrade
Investing Cash Flow
68.8654.9565.2425.2-45.81-172.11
Upgrade
Issuance of Common Stock
0.068.870.140.43166.99228.75
Upgrade
Other Financing Activities
----1.79-0.34-
Upgrade
Financing Cash Flow
0.068.870.14-1.35166.66228.75
Upgrade
Net Cash Flow
32.8615.86-12.89-94.36-6.04-23.87
Upgrade
Free Cash Flow
-36.1-47.99-78.41-120.48-144.52-81.67
Upgrade
Free Cash Flow Per Share
-11.65-15.89-28.65-44.27-54.19-42.30
Upgrade
Levered Free Cash Flow
-18.26-27.55-48.22-76.01-91.09-44.18
Upgrade
Unlevered Free Cash Flow
-18.26-27.55-48.22-76.01-91.09-44.18
Upgrade
Change in Working Capital
-0.5-4.025.34-8.4911.4214.44
Upgrade
Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q